Notice of Re-Establishment

---
identifier: "/us/fr/03-27913"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice of Re-Establishment"
title_number: 0
title_name: "Federal Register"
section_number: "03-27913"
section_name: "Notice of Re-Establishment"
positive_law: false
currency: "2003-11-06"
last_updated: "2003-11-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Office of National Drug Control Policy"
document_number: "03-27913"
document_type: "notice"
publication_date: "2003-11-06"
agencies:
  - "Office of National Drug Control Policy"
fr_citation: "68 FR 62837"
fr_volume: 68
fr_action: "Notice of Re-Establishment of Drug Control Research, Data, and Evaluation Committee."
---


#  Notice of Re-Establishment

**AGENCY:**

Office of National Drug Control Policy.

**ACTION:**

Notice of Re-Establishment of Drug Control Research, Data, and Evaluation Committee.

**SUMMARY:**

Pursuant to the Federal Advisory Committee Act, 5 U.S.C. App. 2 and 41 CFR part 101-6.1013, the Office of National Drug Control Policy re-established the Charter of the Drug Control Research, Data, and Evaluation Committee on October 29, 2003. The re-established charter is available for viewing through the Library of Congress and the United States General Services Administration.

**FOR FURTHER INFORMATION CONTACT:**

Please direct any questions to Daniel Petersen, Assistant General Counsel, (202) 395-6622, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503.

Daniel Petersen,

Assistant General Counsel.